The Society for Immunotherapy of Cancer (SITC) is the world’s leading member society of medical professionals dedicated to advancing cancer immunotherapy and biological therapy through its initiatives, educational sessions, and collaborative endeavors.
SITC has become the premier forum for innovative discussions in the field and remains a central provider of scientific information for its diverse members serving in academia, industry, and regulatory agencies in the U.S. and abroad.